Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis von Aslam, Aisha A, Higgins, Colin, Sinha, Ian P, Southern, Kevin W, Southern, Kevin W

Volltext

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation von Farrell, Philip M., MD, PhD, White, Terry B., PhD, Ren, Clement L., MD, Hempstead, Sarah E., MS, Accurso, Frank, MD, Derichs, Nico, MD, Howenstine, Michelle, MD, McColley, Susanna A., MD, Rock, Michael, MD, Rosenfeld, Margaret, MD, MPH, Sermet-Gaudelus, Isabelle, MD, PhD, Southern, Kevin W., MBChB, PhD, Marshall, Bruce C., MD, Sosnay, Patrick R., MD

Volltext

Newborn screening for cystic fibrosis von Castellani, Carlo, Dr, Massie, John, Prof, Sontag, Marci, PhD, Southern, Kevin W, Prof

Volltext

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del) von Southern, Kevin W, Southern, Kevin W, Murphy, Jared, Sinha, Ian P, Nevitt, Sarah J

Volltext

Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis von Francis, Natalie Z, Francis, Natalie Z, Southern, Kevin W

Volltext

Future therapies for cystic fibrosis von Allen, Lucy, Allen, Lorna, Carr, Siobhan B., Davies, Gwyneth, Downey, Damian, Egan, Marie, Forton, Julian T., Gray, Robert, Haworth, Charles, Horsley, Alexander, Smyth, Alan R., Southern, Kevin W., Davies, Jane C.

Volltext

Autogenic drainage for airway clearance in cystic fibrosis von McCormack, Pamela, Burnham, Paul, Southern, Kevin W, McCormack, Pamela

Volltext

Achieving respiratory excellence in pre-school children with cystic fibrosis von Southern, Kevin W

Volltext

Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research von Johnson, Faye, Ulph, Fiona, MacLeod, Rhona, Southern, Kevin W

Volltext

Macrolide antibiotics (including azithromycin) for cystic fibrosis von Southern, Kevin W, Southern, Kevin W, Solis-Moya, Arturo, Kurz, Dominiki, Smith, Sherie

Volltext

Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis von Ren, Clement L., MD, Borowitz, Drucy S., MD, Gonska, Tanja, MD, Howenstine, Michelle S., MD, Levy, Hara, MD, Massie, John, MBBS, FRACP, PhD, Milla, Carlos, MD, Munck, Anne, MD, Southern, Kevin W., MBChB, PhD

Volltext

Macrolide antibiotics for cystic fibrosis von Southern, Kevin W, Barker, Pierre M, Solis‐Moya, Arturo, Patel, Latifa, Southern, Kevin W

Volltext

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study von Davies, Jane C, Prof, Cunningham, Steve, MBChB, Harris, William T, MD, Lapey, Allen, MD, Regelmann, Warren E, MD, Sawicki, Gregory S, MD, Southern, Kevin W, MBChB, Robertson, Sarah, PharmD, Green, Yulia, MBChB, Cooke, Jon, MSc, Rosenfeld, Margaret, Prof

Volltext

Impact of COVID-19 on people with cystic fibrosis von Colombo, Carla, Burgel, Pierre-Régis, Gartner, Silvia, van Koningsbruggen-Rietschel, Silke, Naehrlich, Lutz, Sermet-Gaudelus, Isabelle, Southern, Kevin W

Volltext

Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy von Southern, Kevin W, Barben, Jürg, Goldring, Stephen, Kneen, Rachel, Southward, Suzanne, Rajeev, Yashasvi, Davies, Jane C, Bush, Andrew

Volltext

ECFS best practice guidelines: the 2018 revision von Castellani, Carlo, Duff, Alistair J.A., Bell, Scott C., Heijerman, Harry G.M., Munck, Anne, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Southern, Kevin W., Barben, Jurg, Flume, Patrick A., Hodková, Pavla, Kashirskaya, Nataliya, Kirszenbaum, Maya N., Madge, Sue, Oxley, Helen, Plant, Barry, Schwarzenberg, Sarah Jane, Smyth, Alan R., Taccetti, Giovanni, Wagner, Thomas O.F., Wolfe, Susan P., Drevinek, Pavel

Volltext

COVID-19 infection in children von Sinha, Ian P, Harwood, Rachel, Semple, Malcolm G, Hawcutt, Daniel B, Thursfield, Rebecca, Narayan, Omendra, Kenny, Simon E, Viner, Russell, Hewer, Simon Langton, Southern, Kevin W

Volltext

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del) von Southern, Kevin W, Heneghan, Matthew, Southern, Kevin W, Murphy, Jared, Sinha, Ian P, Nevitt, Sarah J

Volltext

Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis von Southern, Kevin W, Aslam, Aisha A, Sinha, Ian P, Southern, Kevin W

Volltext

Exercise versus airway clearance techniques for people with cystic fibrosis von Heinz, Katie D, Heinz, Katie D, Walsh, Adam, Southern, Kevin W, Johnstone, Zoe, Regan, Kate H

Volltext